Trials / Sponsors / Advenchen Laboratories Nanjing Ltd.
Advenchen Laboratories Nanjing Ltd.
Industry · 7 registered clinical trials — 3 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | Catequentinib Hydrochloride (AL3818) Drug-Drug Interaction Study in Healthy Volunteers Healthy Volunteer | Phase 1 | 2026-03-02 |
| Completed | A Study of AL8326 in Healthy Subjects Small Cell Lung Cancer, Solid Tumors | Phase 1 | 2025-02-21 |
| Recruiting | A Phase IIII Study of AL8326 in Small Cell Lung Cancer Small Cell Lung Carcinoma | Phase 3 | 2023-10-26 |
| Unknown | A Study of Diet Influence of AL8326 in Chinese Healthy Adult Subjects Diet, High-Fat, Pharmacokinetics | Phase 1 | 2022-06-21 |
| Recruiting | A Study of AL58805 in Patients With Advanced Tumors Advanced Tumors | Phase 1 | 2020-12-20 |
| Unknown | A Phase Ib / IIA Study of AL8326 in Small Cell Lung Cancer Small Cell Lung Cancer | Phase 1 / Phase 2 | 2020-10-19 |
| Unknown | A Phase I Study of AL8326 in Advanced Solid Tumor Advanced Solid Tumors | Phase 1 | 2017-08-17 |